- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-13-0001365

About Zenacts Pharma Private Limited
Data last updated:
Zenacts Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2013PTC034396. Its GSTIN is 06AAACZ6487F1Z0 (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Cheena Kapoor and Pankaj Kumar.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 434 2nd Floor Motor Market Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.74 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹33 Lakh (net margin 1.3%) and EBITDA of ₹1.14 Cr (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Zenacts Pharma and Critivox Criticare. As per MCA filings, the company has open charges of ₹3.81 Cr on record. Court records list 8 cases involving the company, including 1 filed by the company and 5 filed against it.
Zenacts Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0001365). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zenactspharma.com.
Recognitions & Rankings of Zenacts Pharma
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressScf 434 2nd Floor Motor Market Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Zenacts Pharma Private Limited
Zenacts Pharma operates two associated brands: Zenacts Pharma and Critivox Criticare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Contract manufacturing services for tablets, capsules, injectables, syrups, and ointments | zenactspharma.com | |
| Manufacturer of generic finished dosage forms | critivoxcriticare.com |
Business Activity of Zenacts Pharma Private Limited
The main business activity of Zenacts Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Zenacts Pharma Private Limited FY 2025 filings available
Zenacts Pharma Private Limited reported revenue of ₹24.74 Cr (down 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Zenacts Pharma Private Limited
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Zenacts Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.14 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹33 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Zenacts Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Zenacts Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Zenacts Pharma Private Limited
Zenacts Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Cheena Kapoor | Director | 21 Jan 2023 | 3 Years 9 Months | Current |
| Pankaj Kumar Also directs: Tanishka Pharmaceuticals Private Limited | Director | 20 Mar 2013 | 13 Years 7 Months | Current |
Peer Comparison of Zenacts Pharma Private Limited
Zenacts Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Artura Pharmaceuticals Private Limited | ₹24.89 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Chennai, Tamil Nadu, India |
| Greentech Laboratories Private Limited | ₹24.88 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Srikakulam, Andhra Pradesh, India |
| Us Amino Private Limited | ₹24.84 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Mavli, Rajasthan, India |
| Walron Healthcare Private Limited | ₹24.8 Cr (FY 2025) | •••• | •••• | 46.0% | •••• | Jaipur, Rajasthan, India |
| Brassica Pharma Private Limited | ₹24.78 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Mumbai, Maharashtra, India |
| Zenacts Pharma Private Limited this company | ₹24.74 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Chandigarh, India |
| Pvpharma Healthcare Private Limited | ₹24.71 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Ahmedabad, Gujarat, India |
| Aptus Pharma Limited | ₹24.64 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Ahmedabad, Gujarat, India |
| Omni-Protech Drugs Private Limited | ₹24.63 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Pune, Maharashtra, India |
| Evinz Drugs Private Limited | ₹24.63 Cr (FY 2020) | •••• | •••• | 5.0% | •••• | Hyderabad, Telangana, India |
| Vats Biotech Private Limited | ₹24.62 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Jamshedpur, Jharkhand, India |
Peers are the five companies nearest above and the five nearest below Zenacts Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Zenacts Pharma Private Limited
Zenacts Pharma Private Limited is audited by Harish Soni & Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Harish Soni & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Zenacts Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Zenacts Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2025 | Hdfc Bank Limited | ₹30.75 Lakh | Open |
| 30 Nov 2022 | Canara Bank | ₹3.5 Cr | Open |
Total charge records: 2 View all charges
Legal Cases of Zenacts Pharma Private Limited
Zenacts Pharma Private Limited has 8 court cases on record: 1 filed by Zenacts Pharma, 5 filed against it, 2 where it is another party. All cases are disposed. Status as checked between 01 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 5 | 0 |
| District courts | 2 | 0 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Appeal | Filed against the company by Sun Pharmaceutical Industries Limited | Disposed |
| Madras High Court | Original application | Filed against the company by Sun Pharmaceutical Industries Limited | Disposed |
| Madras High Court | Court case (C.S(COMM DIV)) | Filed against the company by Sun Pharmaceutical Industries Limited | Disposed |
| Bombay High Court | Court case (COMIP) | Company is another party | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against B Hazra and Co | Disposed |
Full case history
All 8 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Zenacts Pharma Private Limited
Zenacts Pharma Private Limited has a workforce of 3 employees as of Mar 31, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Zenacts Pharma Private Limited
Zenacts Pharma Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Cheena Kapoor was appointed as Director on 21 Jan 2023.
Credit Ratings, Litigation & Regulatory Alerts for Zenacts Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Zenacts Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Zenacts Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Zenacts Pharma Private Limited
Zenacts Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACZ6487F1Z0 | Haryana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Zenacts Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zenacts Pharma Private Limited
Zenacts Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 2013 (13+ years old) and is registered under CIN U24232CH2013PTC034396.
Zenacts Pharma reported revenue of ₹24.74 Cr for FY 2024 (down 10% YoY).
Zenacts Pharma has 2 current directors:
- Cheena Kapoor - Director
- Pankaj Kumar - Director
Zenacts Pharma reported a net profit of ₹33 Lakh (net margin 1.3%) and EBITDA of ₹1.14 Cr (EBITDA margin 4.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Zenacts Pharma is -1% over three years and 2% over five years. In the latest year (FY 2024) revenue fell 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Zenacts Pharma is 06AAACZ6487F1Z0, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Zenacts Pharma is U24232CH2013PTC034396. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zenacts Pharma has 8 court cases on record: 1 filed by the company and 5 filed against it. Most are in the high courts.
Zenacts Pharma was incorporated on 20 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Zenacts Pharma by revenue are Artura Pharmaceuticals Private Limited, Greentech Laboratories Private Limited, Us Amino Private Limited, Walron Healthcare Private Limited, Brassica Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Cheena Kapoor was appointed as Director on 21 Jan 2023. Gulshan Rawat ceased to be Director on 20 Jan 2023. Pragya Sharma ceased to be Director on 20 Jan 2023. Zenacts Pharma has 5 board changes on record in total.